Abeona Therapeutics (ABEO) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ABEO Abeona Therapeutics

Watchlist

6.4100
+0.3800+6.30%

Close Nov 27 16:00 ET

6.3000
-0.1100-1.72%

Post 16:57 ET

278.65MMarket Cap-3126P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025
AccesswireNov 27 07:00 ET
Positive Outlook for Abeona Therapeutics: FDA Acceptance and Strategic Initiatives Reinforce Buy Rating
TipRanksNov 25 06:55 ET · Ratings
Earnings Week Ahead: NVDA, WMT, SNOW, TGT, BIDU, NIO, ZIM, and More
Seeking AlphaNov 18 00:09 ET
Abeona Therapeutics | 10-Q: Q3 2024 Earnings Report
SECNov 14 07:36 ET · Announcements
Express News | Abeona Therapeutics Inc: Current Cash and Cash Equivalents, Credit Facility Are Sufficient Resources to Fund Ops Into 2026
ReutersNov 14 07:32 ET
Abeona Therapeutics | 8-K: Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
SECNov 14 07:31 ET

Comments

$Abeona Therapeutics (ABEO.US)$ Reuters
just
Abeona Therapeutics® Announces Favorable Medicare Reimbursement Decisions for Pz-Cel

$Abeona Therapeutics (ABEO.US)$ Abeona Therapeutics Concludes Type A Meeting With FDA To Align On Upcoming Pz-cel BLA Resubmission, Continues To Expect To Resubmit BLA In Second Half Of 2024

$Abeona Therapeutics (ABEO.US)$
Abeona Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type a Meeting With FDA to Align on Upcoming Pz-Cel Bla Resubmission
Abeona Therapeutics Q2 Income From Operations USD -17.864 Million Vs. IBES Estimate USD -14.6 Million
Abeona Therapeutics 2Q Loss/Shr 26c
Abeona Therapeutics 2Q Net $7.41M
Abeona Therapeutics Q2 Cash & Investments USD 123 Million

$Abeona Therapeutics (ABEO.US)$ Abeona Therapeutics: Beacon to Have Right to Evaluate, for 12-Month Period, Aav204 Capsid for Potential Use in Certain Ophthalmology Indications
Abeona Therapeutics: To Get Upfront Payment Upon Beacon's Exercise of Option to License Aav204, With Extra Payments on Achievement of Milestones

1

$Abeona Therapeutics (ABEO.US)$ Wow.. price target adjusted lower from $28 to $21 and the stock drops like that… still a big upside imo.

Read more

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall

No Data